Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia

Gillian G. Johnson, Ke Lin, Trevor F. Cox, Melanie Oates, David R. Sibson, Richard Eccles, Bryony Lloyd, Laura-Jayne Gardiner, Daniel F. Carr, Munir Pirmohamed, Jonathan C. Strefford, David G. Oscier, David Gonzalez de Castro, Monica Else, Daniel Catovsky, Andrew R. Pettitt

Blood (2013) 122 (26): 4253–4258.

https://doi.org/10.1182/blood-2013-07-516666

Published: 2013

Includes: Supplemental data

Journal Articles

The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies

Duan Wang, Linhao Li, Hui Yang, Stephen S. Ferguson, Maria R. Baer, Ronald B. Gartenhaus, Hongbing Wang

Blood (2013) 121 (2): 329–338.

https://doi.org/10.1182/blood-2012-06-436691

Published: 2013

Includes: Supplemental data

Journal Articles

Genetic Variations in CYP2B6 and Risk of Cyclophosphamide Toxicity in Patients Undergoing Myeloablative Stem Cell Transplantation.

Stacy E Melanson, MD, PhD, Joseph H. Antin, MD, Michael H. Court, PhD, Vincent Ho, Jerome Ritz, MD, Haesook T. Kim, Frank C Kuo, MD, PhD, Janina A Longtine, MD, Petr Jarolim, MD, PhD

Blood (2008) 112 (11): 3289.

https://doi.org/10.1182/blood.V112.11.3289.3289

Published: 2008

Journal Articles

Different Prevalence of Drug Metabolism Gene Polymorphisms (GSTP and GSTT) in FA Patients Compared to a Normal Population.

Moema Nene Santos, MD, Vanderson Rocha, MD, PhD, Dalila Zanette, Pharm, Raphael Porcher, MS, Irina Ionescu, MD, Marli Tavela, Tech, Jean Soulier, MD, PhD, Thierry Leblanc, MD, Gustavo Fisher, MD, André Baruchel, MD, Marco Antonio Zago, MD, Eliane Gluckman, MD

Blood (2005) 106 (11): 106.

https://doi.org/10.1182/blood.V106.11.106.106

Published: 2005

Journal Articles

Pluripotent Unrestricted Somatic Stem Cells (USSC) from Cord Blood Generate Hepatocytes in Vivo, but In Vitro Convert into Immature Endodermal Precursors: The Critical Role of the Biological Niche.

Sandra Sensken, Juergen Enczmann, Ph.D., Thorsten Trapp, Ph.D., Esmail Zanjani, Ph.D., Peter Wernet, MD, Gesine Koegler, Ph.D.

Blood (2004) 104 (11): 3596.

https://doi.org/10.1182/blood.V104.11.3596.3596

Published: 2004

NARROW

CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia

The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies

Genetic Variations in CYP2B6 and Risk of Cyclophosphamide Toxicity in Patients Undergoing Myeloablative Stem Cell Transplantation.

Different Prevalence of Drug Metabolism Gene Polymorphisms (GSTP and GSTT) in FA Patients Compared to a Normal Population.

Pluripotent Unrestricted Somatic Stem Cells (USSC) from Cord Blood Generate Hepatocytes in Vivo, but In Vitro Convert into Immature Endodermal Precursors: The Critical Role of the Biological Niche.

Email alerts

ASH Publications

American Society of Hematology

CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia

The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies

Genetic Variations in CYP2B6 and Risk of Cyclophosphamide Toxicity in Patients Undergoing Myeloablative Stem Cell Transplantation.

Different Prevalence of Drug Metabolism Gene Polymorphisms (GSTP and GSTT) in FA Patients Compared to a Normal Population.

Pluripotent Unrestricted Somatic Stem Cells (USSC) from Cord Blood Generate Hepatocytes in Vivo, but In Vitro Convert into Immature Endodermal Precursors: The Critical Role of the Biological Niche.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only